• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三阴性乳腺癌患者的表型模拟:病例报告。

Phenocopy in a patient with triple negative breast cancer: a case report.

机构信息

Faculdade Evangélica Mackenzie do Paraná , Curitiba , PR , Brazil .

Centro de Aconselhamento e Laboratório Genetika , Curitiba , PR , Brazil .

出版信息

Einstein (Sao Paulo). 2023 Nov 17;21:eRC0319. doi: 10.31744/einstein_journal/2023RC0319. eCollection 2023.

DOI:10.31744/einstein_journal/2023RC0319
PMID:37991089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10691311/
Abstract

A total of 1.67 million breast cancer cases per year are reported worldwide. Of these, 5%-10% are caused by inherited mutations. Phenocopy is a rare phenomenon, with only a few cases reported in the literature. In phenocopies, phenotypes identical to those with genetic origin occur because of environmental factors rather than familial mutations. We describe a case of phenocopy in a 44-year-old female patient with triple-negative breast cancer. The mother and sister wee heterozygous for c.1813delA, p.Ile605TyrfsTer9 in BRCA2 . The patient underwent genetic testing for BRCA1 and BRCA2 and exome sequencing. Familial or other cancer variants were not detected. The most accepted phenocopy theory is that patients without genetic variants but who are carriers of these mutations undergo cellular changes due to environmental factors, increasing the risk of breast cancer. Therefore, the detection of phenocopy in patients with breast cancer is important in clinical practice.

摘要

全球每年报告的乳腺癌病例总数为 167 万例。其中,5%-10%是由遗传突变引起的。表型模拟是一种罕见的现象,文献中仅报道了少数几例。在表型模拟中,由于环境因素而不是家族突变,出现与遗传起源相同的表型。我们描述了一例 44 岁的三阴性乳腺癌患者的表型模拟病例。母亲和姐姐 BRCA2 中的 c.1813delA,p.Ile605TyrfsTer9 为杂合子。患者接受了 BRCA1 和 BRCA2 的基因检测和外显子组测序。未检测到家族或其他癌症变异。最被接受的表型模拟理论是,没有遗传变异但携带这些突变的患者由于环境因素发生细胞变化,增加了乳腺癌的风险。因此,在乳腺癌患者中检测表型模拟在临床实践中很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/10691311/803212b34c3a/2317-6385-eins-21-eRC0319-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/10691311/803212b34c3a/2317-6385-eins-21-eRC0319-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8094/10691311/803212b34c3a/2317-6385-eins-21-eRC0319-gf01.jpg

相似文献

1
Phenocopy in a patient with triple negative breast cancer: a case report.三阴性乳腺癌患者的表型模拟:病例报告。
Einstein (Sao Paulo). 2023 Nov 17;21:eRC0319. doi: 10.31744/einstein_journal/2023RC0319. eCollection 2023.
2
Double Heterozygosity for Rare Deleterious Variants in the and Genes in a Hungarian Patient with Breast Cancer.一名匈牙利乳腺癌患者中 和 基因罕见有害变异的双重杂合性。
Int J Mol Sci. 2023 Oct 18;24(20):15334. doi: 10.3390/ijms242015334.
3
Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.BRCA1和BRCA2基因常见突变的筛查:对突尼斯乳腺癌和/或卵巢癌家族进行基因检测的意义
Bull Cancer. 2014 Nov;101(11):E36-40. doi: 10.1684/bdc.2014.2049.
4
Clinical characteristics and genetic analysis of a case of a patient with familial hereditary breast cancer: a case report.家族性遗传性乳腺癌 1 例临床特征及遗传学分析:病例报告
J Med Case Rep. 2024 Aug 14;18(1):368. doi: 10.1186/s13256-024-04685-y.
5
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?以色列 BRCA1/BRCA2 突变携带者家族中表型复制型乳腺癌的发生率:非携带者的风险是否增加?
Breast Cancer Res Treat. 2012 Apr;132(2):669-73. doi: 10.1007/s10549-011-1886-3. Epub 2011 Nov 24.
6
Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer.德国和奥地利三阴性乳腺癌女性中BRCA1/2突变状态的评估。
J Cancer Res Clin Oncol. 2015 Nov;141(11):2005-12. doi: 10.1007/s00432-015-1986-2. Epub 2015 May 15.
7
Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer.三阴性乳腺癌和PTEN(磷酸酶和张力蛋白同源物)缺失是早发性和家族性乳腺癌女性中BRCA1种系突变的预测指标,但在散发性晚发性乳腺癌女性中并非如此。
Breast Cancer Res. 2012 Nov 2;14(6):R142. doi: 10.1186/bcr3347.
8
Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer.FANCM 基因内功能丧失性突变与早发性家族性乳腺癌的关联。
JAMA Oncol. 2017 Sep 1;3(9):1245-1248. doi: 10.1001/jamaoncol.2016.5592.
9
[Hereditary breast carcinomas pathologist's perspective].[遗传性乳腺癌:病理学家的观点]
Ann Pathol. 2020 Apr;40(2):78-84. doi: 10.1016/j.annpat.2020.02.023. Epub 2020 Mar 30.
10
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.BRCA1/2基因变异在中国未筛选乳腺癌患者中的患病率及预后作用
PLoS One. 2016 Jun 3;11(6):e0156789. doi: 10.1371/journal.pone.0156789. eCollection 2016.

本文引用的文献

1
Sociodemographic and Clinical-pathological Study of Molecular Subtitles of Breast Carcinoma in a Reference Unit of Maranhão.巴西马拉尼昂州参考单位乳腺癌分子亚型的社会人口学和临床病理学研究
Rev Bras Ginecol Obstet. 2020 Dec;42(12):820-828. doi: 10.1055/s-0040-1719147. Epub 2020 Dec 21.
2
BRCA genes: BRCA 1 and BRCA 2.BRCA基因:BRCA 1和BRCA 2。
J BUON. 2018 Jul-Aug;23(4):862-866.
3
Risk Factors and Preventions of Breast Cancer.乳腺癌的风险因素与预防。
Int J Biol Sci. 2017 Nov 1;13(11):1387-1397. doi: 10.7150/ijbs.21635. eCollection 2017.
4
Breast Cancer Epidemiology, Prevention, and Screening.乳腺癌流行病学、预防和筛查。
Prog Mol Biol Transl Sci. 2017;151:1-32. doi: 10.1016/bs.pmbts.2017.07.002. Epub 2017 Oct 10.
5
Awareness and current knowledge of breast cancer.对乳腺癌的认识及当前知识
Biol Res. 2017 Oct 2;50(1):33. doi: 10.1186/s40659-017-0140-9.
6
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriers.所有年龄段中 BRCA1/BRCA2 突变家族的表型模拟率增加,但前瞻性乳腺癌风险增加仅限于 BRCA2 突变携带者。
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2269-76. doi: 10.1158/1055-9965.EPI-13-0316-T. Epub 2013 Nov 27.
7
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?以色列 BRCA1/BRCA2 突变携带者家族中表型复制型乳腺癌的发生率:非携带者的风险是否增加?
Breast Cancer Res Treat. 2012 Apr;132(2):669-73. doi: 10.1007/s10549-011-1886-3. Epub 2011 Nov 24.
8
BRCA phenocopies or ascertainment bias?BRCA基因拟表型还是确诊偏倚?
J Med Genet. 2007 Aug;44(8):e86; author reply e88.
9
A survey of preventive measures among BRCA1 mutation carriers from Poland.波兰BRCA1基因变异携带者预防措施的调查。
Clin Genet. 2007 Feb;71(2):153-7. doi: 10.1111/j.1399-0004.2007.00742.x.